Stem cell treatment for severe leg artery disease
Part of Heart & circulation clinical trials.
This trial tests whether injecting stem cells from donated fat tissue can help people with severe blockages in leg arteries who cannot have surgery or angioplasty. The goal is to see if the treatment is safe and if it can improve blood flow and reduce pain or wounds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have severe leg pain or a wound caused by poor blood flow that has lasted at least 15 days.
- Your ankle blood pressure is very low (or a special test shows poor blood flow in your foot).
- Doctors have decided that a procedure to reopen your leg arteries is not possible, or it has not worked well enough.
- You are expected to live at least 6 more months.
- You are not already in another trial for a new drug or treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether stem cells from umbilical cord arteries can help people with severe leg pain or ulcers due to blocked arteries. It is for those who cannot have surgery or other procedures.
This trial tests whether a stem cell product (Stempeucel®) can improve healing and safety for people with critical limb ischemia caused by peripheral artery disease. It is for patients who cannot have (or have already tried) procedures to reopen blocked leg arteries and who have a leg ulcer and low blood-flow measurements.
This trial tests whether a stem cell product (Stempeucel®) is safe and effective for people with Buerger’s disease causing critical limb ischemia and foot ulcers. It may help improve healing and blood flow when other options may be limited.
This trial tests a new minimally invasive procedure (placing a small stent) to improve blood flow to a severely threatened foot or lower leg. It may help people whose ulcers or gangrene are not treatable with standard bypass or other surgeries.
This trial tests an experimental drug for people with critical limb ischemia, a serious condition where not enough blood reaches the legs. It aims to see if the drug can help with pain or healing of leg ulcers without the need for surgery.
This study follows adults with very poor blood flow to the foot or leg (with wounds or severe pain) who are having a revascularization procedure to improve circulation. It may help doctors understand outcomes after treatment and improve care for people with critical limb ischemia.
Hear when a new Critical Limb Ischemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.